Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Harvard Business School
Chinese Patent Office
Covington
Mallinckrodt
Daiichi Sankyo
Moodys
QuintilesIMS
Teva

Generated: September 23, 2018

DrugPatentWatch Database Preview

Alkem Company Profile

« Back to Dashboard

What is the competitive landscape for ALKEM, and what generic and branded alternatives to ALKEM drugs are available?

ALKEM has thirty-eight approved drugs.

There are seven tentative approvals on ALKEM drugs.

Summary for Alkem
US Patents:0
Tradenames:34
Ingredients:34
NDAs:38
Patent Litigation for Alkem: See patent lawsuits for Alkem

Drugs and US Patents for Alkem

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alkem Labs Ltd TAMSULOSIN HYDROCHLORIDE tamsulosin hydrochloride CAPSULE;ORAL 207405-001 Aug 11, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Alkem Labs Ltd RASAGILINE MESYLATE rasagiline mesylate TABLET;ORAL 201889-001 Oct 30, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Alkem Labs Ltd LAMOTRIGINE lamotrigine TABLET;ORAL 200694-004 Jun 14, 2013 AB RX No No ➤ Sign Up ➤ Sign Up
Alkem Labs Ltd MYCOPHENOLATE MOFETIL mycophenolate mofetil CAPSULE;ORAL 200197-001 Jun 13, 2013 AB RX No No ➤ Sign Up ➤ Sign Up
Alkem GABAPENTIN gabapentin CAPSULE;ORAL 090858-002 Dec 17, 2010 AB RX No No ➤ Sign Up ➤ Sign Up
Alkem Labs Ltd FESOTERODINE FUMARATE fesoterodine fumarate TABLET, EXTENDED RELEASE;ORAL 204827-001 Dec 10, 2015 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
AstraZeneca
Covington
Deloitte
US Army
Julphar
Moodys
Harvard Business School
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.